Ruxolitinib withdrawal due to the COVID-19

Leukemia. 2021 Apr;35(4):1218. doi: 10.1038/s41375-021-01214-4. Epub 2021 Mar 17.

Marko Lucijanic^{1

2}, Rajko Kusec^{3

4

5}

¹ Hematology Department, University Hospital Dubrava, Zagreb, Croatia. markolucijanic@yahoo.com.
² University of Zagreb School of Medicine, Zagreb, Croatia. markolucijanic@yahoo.com.
³ Hematology Department, University Hospital Dubrava, Zagreb, Croatia.
⁴ University of Zagreb School of Medicine, Zagreb, Croatia.
⁵ Division of Molecular Diagnosis and Genetics, Clinical Department of Laboratory Diagnostics, University Hospital Dubrava, Zagreb, Croatia.

No abstract available

Publication types